Page last updated: 2024-08-25

1-ethyl-2-benzimidazolinone and Glioma

1-ethyl-2-benzimidazolinone has been researched along with Glioma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsieh, YJ; Hsu, CW; Huang, CW; Huang, YM; Hung, TY; Sze, CI; Wu, SJ; Wu, SN; Yeh, PS1
Alzheimer, C; Burgstahler, R; Kaesler, S; Koegel, H; Werner, S1

Other Studies

2 other study(ies) available for 1-ethyl-2-benzimidazolinone and Glioma

ArticleYear
Evidence for the Inhibition by Temozolomide, an Imidazotetrazine Family Alkylator, of Intermediate-Conductance Ca2+-Activated K+ Channels in Glioma Cells.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 38, Issue:5

    Topics: Alkylating Agents; Benzimidazoles; Cell Line, Tumor; Dacarbazine; DNA Damage; Glioma; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Ionomycin; Large-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Temozolomide

2016
Unexpected down-regulation of the hIK1 Ca2+-activated K+ channel by its opener 1-ethyl-2-benzimidazolinone in HaCaT keratinocytes. Inverse effects on cell growth and proliferation.
    The Journal of biological chemistry, 2003, Jan-31, Volume: 278, Issue:5

    Topics: Benzimidazoles; Calcium Channel Agonists; Cell Division; Cell Line; Gene Expression Regulation; Glioma; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Ion Channel Gating; Keratinocytes; Kinetics; Membrane Potentials; Potassium Channels; Potassium Channels, Calcium-Activated; RNA, Messenger; Tumor Cells, Cultured

2003